XNYS
CVSA
Market cap4.76bUSD
Jul 10, Last price
130.90USD
1D
-0.32%
1Q
16.83%
Jan 2017
319.55%
Name
Adtalem Global Education Inc
Chart & Performance
P/E
20.06
P/S
2.66
EPS
6.53
Div Yield, %
—
Shrs. gr., 5y
-6.66%
Rev. gr., 5y
15.60%
Revenues
1.79b
+12.85%
Net income
237m
+73.32%
CFO
338m
+14.24%
Dividend
Nov 30, 20160.18 USD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Adtalem Global Education Inc. is a global enterprise dedicated to delivering comprehensive workforce and educational solutions. Established in 1987 and headquartered in Chicago, Illinois, the company was formerly known as DeVry Education Group Inc. until its name change in May 2017. The organization operates through three distinct segments: 1. Chamberlain: This division offers both academic degree programs and specialized non-degree coursework within the nursing and health professions postsecondary education sector, primarily facilitated by Chamberlain University. 2. Walden: Focused on online learning, the Walden segment provides a wide array of qualifications, from certificates and bachelor's degrees to master's and doctoral programs. These offerings, delivered via Walden University, span numerous fields including nursing, education, counseling, business, psychology, public health, social work, human services, public administration, public policy, and criminal justice. 3. Medical and Veterinary: This segment is committed to postsecondary education in medical and veterinary sciences, furnishing students with both degree and non-degree program options. Its institutions include the American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||